Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
20
pubmed:dateCreated
2006-9-28
pubmed:abstractText
All stereoisomers of adenine and guanine methylene-3-fluoromethylenecyclopropane analogues of nucleosides 9a, 9b, 10a, 10b, 11a, 11b, 12a, and 12b were synthesized and their antiviral activities were evaluated. A highly convergent approach permitted the synthesis of all these analogues using a single intermediate 15. Reaction of aldehyde 13 with fluorotrichloromethane and tri-n-butylphosphine gave fluoroalkenes 14a+14b (83:17). Addition of carbene derived from ethyl diazoacetate gave cyclopropane 15 as the major product. Reduction (19), bromination (20), and phenylselenenylation (21), followed by Se oxidation and beta-elimination gave cis-methylenecyclopropane 22. Addition of bromine provided the reagent 23 for alkylation-elimination. Reaction of 23 with adenine led to an isomeric mixture 25a+26a that after deprotection afforded analogues 9a and 10a. The 2-amino-6-chloropurine furnished 25e+26e and after deblocking (9e and 10e) and hydrolysis gave targets 9b and 10b. Intermediate 15 provided, after debenzylation (27), 2-nitrophenylselenenylation (28), reduction (29), benzylation (30), and oxidation-elimination trans-methylenecyclopropane 31. Addition of bromine gave reagent 32. Further transformations followed the sequence outlined for analogues 9a, 9b, 10a, and 10b. Analogue 9b was effective against human cytomegalovirus (HCMV; Towne) with EC50 2.9 microM. The trans-isomer 10b inhibited AD169 strain of HCMV (EC50 15 microM) and the murine virus MCMV (EC50 2.5 microM). Compound 12a was effective against Epstein-Barr virus (EC50<0.03 microM). Analogue 9a inhibited varicella zoster virus (EC50 5.9 microM) and human immunodeficiency virus type 1 (EC50 5.2 microM). Analogues 9a, 10a, and 11a are moderate substrates for adenosine deaminase. The structure-activity relationships will be discussed in context with other methylenecyclopropane analogues.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0022-2623
pubmed:author
pubmed:issnType
Print
pubmed:day
5
pubmed:volume
49
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
6120-8
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:17004726-Adenine, pubmed-meshheading:17004726-Adenosine Deaminase, pubmed-meshheading:17004726-Antiviral Agents, pubmed-meshheading:17004726-Cyclopropanes, pubmed-meshheading:17004726-Cytomegalovirus, pubmed-meshheading:17004726-Cytopathogenic Effect, Viral, pubmed-meshheading:17004726-Guanine, pubmed-meshheading:17004726-HIV-1, pubmed-meshheading:17004726-Hepatitis B virus, pubmed-meshheading:17004726-Herpesvirus 1, Human, pubmed-meshheading:17004726-Herpesvirus 2, Human, pubmed-meshheading:17004726-Herpesvirus 3, Human, pubmed-meshheading:17004726-Herpesvirus 4, Human, pubmed-meshheading:17004726-Humans, pubmed-meshheading:17004726-Purine Nucleosides, pubmed-meshheading:17004726-Stereoisomerism, pubmed-meshheading:17004726-Structure-Activity Relationship, pubmed-meshheading:17004726-Viral Plaque Assay
pubmed:year
2006
pubmed:articleTitle
9-{[3-fluoro-2-(hydroxymethyl)cyclopropylidene]methyl}adenines and -guanines. Synthesis and antiviral activity of all stereoisomers1.
pubmed:affiliation
Department of Chemistry, Developmental Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan 48201-1379, USA.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural